Medical University of Vienna
Medical University of Vienna
Vienna, Austria35 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients | COVID-19, Coronaviridae Infections, Critical Illness, Disease Attributes, Infections, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, lung disorder, nutritional deficiency disease, nutritional disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia, vitamin D deficiency, vitamin deficiency disorder | Active, not recruiting | Phase 3 | 2026-10-09 | NCT03188796 | |
| Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe | Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute liver failure, chronic liver failure, cirrhosis of liver, liver disorder, liver failure | Recruiting | Not stated | 2026-10-08 | NCT07585890 | |
| Vorasidenib Maintenance for IDH Mutant Astrocytoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-10-07 | NCT06809322 | |
| The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) | Arterial Occlusive Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, heart failure, myocardial ischemia, systolic heart failure, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT05427370 | |
| Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Recruiting | Not applicable | 2026-09-29 | NCT05865457 | |
| Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis | Brain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-09 | NCT06315010 | |
| Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. | Advanced Breast Cancer; ER-positive Breast Cancer; ESR1 Gene Mutation; HER2-negative Breast Cancer | Recruiting | Phase 3 | 2026-08-24 | NCT06382948 | |
| Cerebellar Mutism Syndrome Study | Neoplasms by Site, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system cancer, central nervous system disorder, communication disorder, language disorder, mutism, neoplasm, nervous system disorder, neurodevelopmental disorder, psychiatric disorder, speech disorder | Recruiting | Not stated | 2026-08-12 | NCT02300766 | |
| Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype | Advanced Breast Cancer; Advanced Breast Carcinoma; Hormone Receptor Positive Breast Carcinoma | Recruiting | Phase 2 | 2026-07-30 | NCT06486883 | |
| Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients | splenic marginal zone lymphoma | Active, not recruiting | Phase 3 | 2026-07-22 | NCT05735834 | |
| Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin | Chemically-Induced Disorders, Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-07-06 | NCT07632716 | |
| Tracking Results of Ablations to Combat AF Registry Generation 2 | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2026-06-29 | NCT05111015 | |
| A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not stated | 2026-06-29 | NCT05110989 | |
| Optimizing the Use of Aspirin for the Prevention of Preeclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Not yet recruiting | Phase 3 | 2026-06-24 | NCT07665853 | |
| Impact of a Tunneled Hemodialysis Catheter With Endexo® Technology on Catheter Dysfunction Compared With Historical Catheter Dysfunction Data in Standard Catheters | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Not applicable | 2026-06-18 | NCT07655544 | |
| Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation | Development of Reporting System for Molecular Diagnosis; Incorporate Molecular Diagnosis Into Diagnostic Standards; Validation Study of Molecular Diagnostic System | Recruiting | Not stated | 2026-06-02 | NCT01299168 | |
| OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-06-01 | NCT07619144 | |
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | Recruiting | Phase 2 / Phase 3 | 2026-05-26 | NCT05416307 | |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve disorder, mitral valve insufficiency | Recruiting | Not stated | 2026-05-07 | NCT04688190 | |
| Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 2 | 2026-04-27 | NCT05177835 | |
| 10°C vs 4°C Lung Preservation RCT | Lung Transplant; Organ Preservation | Active, not recruiting | Not applicable | 2026-03-19 | NCT05898776 | |
| Supramarginal Resection in Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Not applicable | 2026-03-03 | NCT04243005 | |
| Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; Stage IA1 Endometrial Cancer FIGO 2023; Stage IA2 Endometrial Cancer FIGO 2023 | Recruiting | Not stated | 2026-02-19 | NCT06689956 | |
| Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary? | Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, disease, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-02-18 | NCT07418450 | |
| LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment. | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not applicable | 2026-01-29 | NCT07376135 |